Gastroenterology News

  • Alert FDA Clears Pan-Genotypic Vosevi for Chronic Hepatitis C Vosevi, a combo of two previously approved drugs and newly approved voxilaprevir, is the first treatment approved for patients who have been previously treated with the direct-acting antiviral drug sofosbuvir or NS5A inhibitors.
 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Early-Life Depression Boosts Alzheimer's RiskDepression that starts early in life increases the risk for Alzheimer's disease in novel findings from a longitudinal study that is the first to report this association.
  • Emergency Visits Common After Hysterectomy, Study FindsApproximately one in 11 women who undergo hysterectomy for benign disease make potentially avoidable visits to the emergency department within 30 days of the surgery, a new study showed.

Perspective

Business of Medicine

Columnists

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape